BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 15317642)

  • 1. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
    Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
    Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.
    Eisenberg MJ; Grandi SM; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Sarrafzadegan N; Sharma S; Lauzon C; Yadav R; Pilote L;
    J Am Coll Cardiol; 2013 Feb; 61(5):524-32. PubMed ID: 23369417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
    Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
    Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L; Warncke W; Herschel M
    Pneumologie; 2004 Mar; 58(3):140-6. PubMed ID: 15007784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
    Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
    J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
    Chatkin JM; Mariante de Abreu C; Haggsträm FM; Wagner MB; Fritscher CC
    Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of bupropion in the indigenous Maori population in New Zealand.
    Holt S; Timu-Parata C; Ryder-Lewis S; Weatherall M; Beasley R
    Thorax; 2005 Feb; 60(2):120-3. PubMed ID: 15681499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
    Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD
    Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
    Toll BA; Leary V; Wu R; Salovey P; Meandzija B; O'Malley SS
    Addict Behav; 2008 Jan; 33(1):173-9. PubMed ID: 17587504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.
    Wilkes S; Evans A; Henderson M; Gibson J
    Postgrad Med J; 2005 Nov; 81(961):719-22. PubMed ID: 16272237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
    Croghan IT; Hurt RD; Dakhil SR; Croghan GA; Sloan JA; Novotny PJ; Rowland KM; Bernath A; Loots ML; Le-Lindqwister NA; Tschetter LK; Garneau SC; Flynn KA; Ebbert LP; Wender DB; Loprinzi CL
    Mayo Clin Proc; 2007 Feb; 82(2):186-95. PubMed ID: 17290726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
    Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
    Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.